BIOXYNE LIMITED has not announced a capital raise, but we are collating interest in any future round. Pledge your support and we will let the company know of your interest.
Bioxyne Limited (BXN) is an Australian life science, health and medical technology company with a focus on immune health and immunotherapeutic products. Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC. Former Names VRI Biomedical Ltd; Probiomics Limited (PCC), 5/04/2012
Suite 506, Level 5/50 Clarence St, Sydney NSW 2000, Australia